One of the future scenarios that I have focused on for some time is healthy life extension. When I mention to an audience that the first person to live to 200 has already been born – it gets quite the reaction. That scenario is not as far-fetched as people believe. This recent article explored research in the field of senolytics – drugs that work to eliminate cells that degrade tissue function. The drugs are already showing promising results and could become available on the market within the next decade.